Business Context and Reporting Period
Company: Clearmind Medicine Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: May 2026 (Announcement Date: May 19, 2026)
Principal Executive Offices: Vancouver, British Columbia
The Company announced a 1-for-10 reverse share split of its common shares. Trading on the Nasdaq Capital Market under the new structure is scheduled to commence on Thursday, May 21, 2026.
Key Financial Metrics
This filing is a corporate action announcement and does not contain financial performance data. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Share Consolidation: Each ten (10) common shares will be consolidated into one (1) common share.
- Outstanding Shares: The number of issued and outstanding common shares will adjust from 10,190,337 to approximately 1,019,033.
- Fractional Shares: No fractional shares will be issued; all fractional interests will be rounded up to the nearest whole share.
- Derivatives: Proportionate adjustments will be made to the per-share exercise price and the number of shares issuable for all outstanding warrants and options.
- Authorized Capital: The Company's authorized share capital will remain unchanged.
- Identification: The new CUSIP number for the common shares will be 185053600.
Guidance, Outlook, and Risks
The filing incorporates by reference the "Forward-Looking Statements" section of the attached press release (Exhibit 99.1) but does not explicitly detail specific guidance, risks, or contingencies within the body of this Form 6-K text. The primary purpose is to disclose the mechanics and timing of the reverse split.
Investor Verification Checklist
- Verify the new CUSIP number (185053600) for trading purposes.
- Confirm the exact number of shares held post-split, noting the rounding up of fractional shares.
- Review the adjusted exercise prices and share counts for any held options or warrants.
- Check the Nasdaq Capital Market trading status effective May 21, 2026.